Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Neurologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Migraine: Epidemiology, Burden, and Comorbidity.Neurol Clin. 2019; 37: 631-649
- Pediatric Migraine.Neurol Clin. 2009; 27: 481-501
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017; 390: 1211-1259
- Migraine is first cause of disability in under 50s: will health politicians now take notice?.J Headache Pain. 2018; https://doi.org/10.1186/s10194-018-0846-2
- Young people’s health - A challenge for society.World Heal Organ - Tech Rep Ser. 1986; 731: 1-117
- Development of a patient-based grading scale for PedMIDAS.Cephalalgia. 2004; 24: 844-849
- New daily persistent headache: A systematic review on an enigmatic disorder.J Headache Pain. 2019; https://doi.org/10.1186/s10194-019-1022-z
- New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series.Cephalalgia. 2019; 39: 785-791
- New Daily Persistent Headache Is Most Likely to Begin at the Start of School.J Child Neurol. 2016; 31: 864-868
- New Daily Persistent Headache in a Pediatric Population.J Child Neurol. 2021; 36: 888-893
- Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis.Cephalalgia. 2021; 41: 1382-1395
- Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.Neurology. 2019; 93: 487-499
- Short-term treatment of Migraine in Children and Adolescents.JAMA. 2020; 174: 789-790
- Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study.Neurology. 1997; 48: 103-107
- Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.Headache. 2020; 60: 58-70
- Treatment of chronic migraine: A 3-month comparator study of naproxen sodium vs SumaRT/Nap.Headache. 2014; 54: 80-93
- Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials.Lancet. 2001; 358: 1668-1675
- Tolerability and effectiveness of prochlorperazine for intractable migraine in children.Pediatrics. 2001; 107https://doi.org/10.1542/peds.107.4.e62
- Prochlorperazine in children with migraine: A look at its effectiveness and rate of akathisia.Am J Emerg Med. 2012; 30: 456-463
- Treatment of Pediatric Migraine Headaches: A Randomized, Double-Blind Trial of Prochlorperazine Versus Ketorolac.Ann Emerg Med. 2004; 43: 256-262
- Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department.J Emerg Med. 2010; 39: 166-173
- Chlorpromazine for the treatment of migraine in a pediatric emergency department.Headache. 2014; 54: 335-342
- A prospective, randomized, double-blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department.Headache. 2021; 61: 603-611
- The acute treatment of migraine in adults: The american headache society evidence assessment of migraine pharmacotherapies.Headache. 2015; 55: 3-20
- Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.Am J Emerg Med. 1996; 14: 262-264
- A Randomized Controlled Trial of Prochlorperazine Versus Metoclopramide for Treatment of Acute Migraine.Ann Emerg Med. 2008; 52: 399-406
- Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.Brain. 2019; 142: 1894-1904
- Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.Lancet. 2019; 394: 737-745
- Ubrogepant for the Treatment of Migraine.N Engl J Med. 2019; 381: 2230-2241
- Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion.J Clin Sleep Med. 2016; 12: 1549-1561
- Developmental changes in sleep biology and potential effects on adolescent behavior and caffeine use.Nutr Rev. 2014; 72: 60-64
- Sleep and use of electronic devices in adolescence: Results from a large population-based study.BMJ Open. 2015; 5: 1-7
- Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance.J Appl Physiol. 2011; 110: 1432-1438
- Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality.Eur J Nutr. 2012; 51: 909-916
- Relationship of childhood headaches with preferences in leisure time activities, depression, anxiety and eating habits: A population-based, cross-sectional study.Cephalalgia. 2015; 35: 527-537
- Towards improved migraine management: Determining potential trigger factors in individual patients.Cephalalgia. 2017; 37: 452-463
- High School Start Time and Migraine Frequency in High School Students.Headache. 2019; 59: 1024-1031
- Pathophysiology of Migraine: A Disorder of Sensory Processing.Physiol Rev. 2017; 97: 553-622
- The prevalence of premonitory symptoms in paediatric migraine: A questionnaire study in 103 children and adolescents.Cephalalgia. 2009; 29: 1197-1201
- The Migraine Premonitory Phase.Contin Lifelong Learn Neurol. 2018; 24: 996-1008
- Dehydration and Headache.Curr Pain Headache Rep. 2021; 25: 4-9
- Mild dehydration modifies the cerebrovascular response to the cold pressor test.Exp Physiol. 2016; 101: 135-142
- Prevalence of inadequate hydration among US children and disparities by gender and race/ethnicity: National Health and Nutrition Examination Survey, 2009-2012.Am J Public Health. 2015; 105: e113-e118
- A randomized trial on the effects of regular water intake in patients with recurrent headaches.Fam Pract. 2012; 29: 370-375
- Association of drinking water and migraine headache severity.J Clin Neurosci. 2020; 77: 81-84
Medicine I of. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate.; 2005. doi:10.17226/10925.
- The association between migraine and physical exercise.J Headache Pain. 2018; 19: 83
- An unfavorable lifestyle and recurrent headaches among adolescents: The HUNT Study.Neurology. 2010; 75: 712-717
- Obesity and migraine: A population study.Neurology. 2006; 66: 545-550
- Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls.Cephalalgia. 2011; 31: 1428-1438
- Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: A randomized comparative study.Arq Neuropsiquiatr. 2014; 72: 851-855
- Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention.Neurology. 2019; https://doi.org/10.1212/wnl.0000000000008105
- Trial of amitriptyline, topiramate, and placebo for pediatric migraine.N Engl J Med. 2017; https://doi.org/10.1056/NEJMoa1610384
- Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.Pediatr Neurol. 2021; 114https://doi.org/10.1016/j.pediatrneurol.2020.09.009
- Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.Restor Neurol Neurosci. 2017; 35: 385-393
- Research paper: Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.J Neurol Neurosurg Psychiatry. 2016; 87: 1127
- Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.BMJ Open. 2021; 11https://doi.org/10.1136/BMJOPEN-2020-039358
- Magnesium in Migraine Prophylaxis—Is There an Evidence-Based Rationale? A Systematic Review.Headache J Head Face Pain. 2018; 58: 199-209
- Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.Headache. 2018; 58https://doi.org/10.1111/head.13414
- CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.Pediatr Neurol. 2021; 114: 62
- Remote electrical neuromodulation for acute treatment of migraine in adolescents.Headache. 2021; 61: 310-317
- Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.Cephalalgia. 2019; 39: 3-14
- No Title.Neurol Sci. 2017; 38: S197-S199
- Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study.Headache. 2018; 58: 724-731
- Nonpainful remote electrical stimulation alleviates episodic migraine pain.Neurology. 2017; 88: 1250-1255
- The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice.Headache. 2021; 61: 1021-1039
- Cognitive-behavioral therapy: How medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine.Headache. 2015; 55: 1382-1396
- Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial.JAMA. 2013; 310: 2622-2630
- Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 per Month.Headache. 2016; 56: 711-716
- Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study.Headache. 2020; 60: 889-901
- Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial.Headache. 2020; 60: 2232-2246
- Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section.Headache. 2016; 56: 1597-1607
- Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.Pediatr Neurol. 2014; 50: 135-139
- The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache.Headache. 2016; 56: 240-258
- A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360® as acute treatment for chronic migraine.Headache. 2015; 55: 101-116
- Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache.Pain Res Treat. 2018; 2018https://doi.org/10.1155/2018/2516953
- Sphenopalatine ganglion nerve block for the treatment of migraine headaches in the pediatric population.Pain Physician. 2021; 24: E111-E116
- Transnasal sphenopalatine ganglion block for the preventive treatment of chronic daily headache in adolescents.Children. 2021; 8: 1-8
- The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review.J Child Neurol. 2020; 35: 844-851
- Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population.Neuropediatrics. 2022; https://doi.org/10.1055/A-1832-9168
- Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients.Cureus. 2019; 11https://doi.org/10.7759/CUREUS.4343
- Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population.Reg Anesth Pain Med. 2021; 46: 41-48
- Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.Pediatr Neurol. 2022; 130: 21-27
Article info
Publication history
Published online: October 29, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
